VANCOUVER, British Columbia--(BUSINESS WIRE)--Jan. 23, 2006--Forbes Medi-Tech Inc. (TSX:FMI)(NASDAQ:FMTI) today announced the extension of a major sterol supply agreement for a minimum of US$4.8 million between Forbes’ manufacturing joint venture, Phyto-Source LP, and a large multinational company. The contract was originally signed in September 2002, renewed in June 2004 and under the latest extension is effective until the end of 2006. For competitive reasons, the identity of the customer and contractual terms and conditions have not been disclosed. “The extension of this agreement is an important event for Forbes as it demonstrates the continued demand for our phytosterol ingredients from an established customer,” said Charles Butt, President and CEO of Forbes Medi-Tech Inc.
